Skip to main content

Day: July 31, 2020

Meso Numismatics Update on 2nd Transaction with Global Stem Cells

LAS VEGAS, NV, July 31, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a technology and numismatic company specializing in the Meso Region, including Central America and the Caribbean, announced today that “the Company has recently successfully made the second payment ($75,000) to Global Stem Cells Group on time as per the company’s LOI amendment dated April 22, 2020.”“We are excited about the pending acquisition of Global Stem Cells Group,” said David Christensen, CEO and President of Meso Numismatics, Inc. “We are extremely optimistic about the opportunities that Stem Cell Biotechnology and the future that Regenerative Medicine can offer the world.”This press release should be read in conjunction with the all other filings on www.sec.govFor more information on Global...

Continue reading

ArcelorMittal announces publication of its 2020 half-year report

31 July 2020, 21:30 CET- ArcelorMittal has today published its half-year report for the six-month period ended 30 June 2020.The report is available on http://corporate.arcelormittal.com/ under Investors > Financial reports > Half-year reports, and on the electronic database of the Luxembourg Stock Exchange (www.bourse.lu/).The report has also been filed on Form 6-K with the U.S. Securities and Exchange Commission (SEC) and is available on http://corporate.arcelormittal.com/ under Investors > Financial reports > SEC filings.ENDSAbout ArcelorMittalArcelorMittal is the world’s leading steel and mining company, with a presence in 60 countries and an industrial footprint in 19 countries. Guided by a philosophy to produce safe, sustainable steel, we are the leading supplier of quality steel in the major global steel markets including...

Continue reading

Allied Corp. Submits Confirmation of Readiness Package to Health Canada for Canadian License

KELOWNA, British Columbia, July 31, 2020 (GLOBE NEWSWIRE) — Allied Corp. (“Allied”) (OTCQB: ALID), an international medical cannabis company focused on creating and providing targeted cannabinoid health solutions to address today’s medical issues, is pleased to announce the submission of a confirmation of readiness package (the “Readiness Package”) to Health Canada for a cultivation license at its new facility in Kelowna, BC.  The Readiness Package was submitted by Allied’s wholly owned subsidiary, Falcon Ridge Inc., a Canadian Licensed Producer applicant.  Submission of the Readiness Package represents the last stage of review and approval before being granted the License to Cultivate cannabis under the Canadian Cannabis Regulations.  When granted, the License to Cultivate enables the license holder to be able to sell...

Continue reading

Genmab Announces European Myeloma Network and Janssen Achieve Positive Topline Results from Phase 3 APOLLO Study of Daratumumab in Combination with Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

Company AnnouncementPhase 3 APOLLO randomized study evaluating subcutaneous daratumumab in combination with pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in relapsed or refractory multiple myeloma met the primary endpoint of improving progression-free survivalJanssen intends to discuss the data with health authorities for potential regulatory submissionsCopenhagen, Denmark; July 31, 2020 – Genmab A/S (Nasdaq: GMAB) announced today that the European Myeloma Network (EMN) in collaboration with Janssen Research & Development, LLC (Janssen) reported positive results from the Phase 3 APOLLO (MMY3013) study of the subcutaneous (SC) formulation of daratumumab in combination with pomalidomide and dexamethasone (Pd) versus Pd alone as treatment for patients with relapsed or refractory multiple myeloma who have...

Continue reading

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccine

Sanofi and GSK in advanced discussions with European Union to supply up to 300 million doses of COVID-19 vaccineDiscussions relate to vaccine candidate using Sanofi’s recombinant protein-based technology combined with GSK’s pandemic adjuvant systemBoth companies are committed to making their COVID-19 vaccine affordable and available globallyPARIS and LONDON – July 31, 2020 – Sanofi and GSK are in advanced discussions, with the European Commission (EC) for the supply of up to 300 million doses of a COVID-19 vaccine. The vaccine candidate developed by Sanofi in partnership with GSK, is based on the recombinant protein-based technology used by Sanofi to produce an influenza vaccine, and GSK’s established adjuvant technology. The doses would be manufactured in European countries including France, Belgium, Germany and Italy. This marks a key...

Continue reading

Sanofi et GSK en discussion avancée avec l’Union européenne pour fournir jusqu’à 300 millions de doses de vaccin COVID-19

Sanofi et GSK en discussion avancée avec l’Union européenne pour fournir jusqu’à 300 millions de doses de vaccin COVID-19La discussion porte sur la technologie à base de de protéine recombinante développée par Sanofi et sur un adjuvant à usage pandémique développé par GSK.Les deux entreprises s’engagent à mettre à disposition leur vaccin contre la Covid-19 à un prix abordable, partout dans le monde.PARIS et LONDRES – Le 31 juillet 2020 – Sanofi et GSK ont conclu des discussions avec la Commission européenne (CE) pour la fourniture de jusqu’à 300 millions de doses d’un vaccin COVID-19. La Commission a accepté de mettre en place un cadre contractuel pour l’achat de doses de vaccin une fois que le vaccin aurait été prouvé sûr et efficace, au nom de tous les États membres de l’UE. Le candidat-vaccin, développé...

Continue reading

Freddie Mac Prices $1.3 Billion Multifamily K-Deal, K-113

MCLEAN, Va., July 31, 2020 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) recently priced a new offering of Structured Pass-Through Certificates (K Certificates), which are backed by underlying collateral consisting of fixed-rate multifamily mortgages with predominantly 10-year terms. The company expects to issue approximately $1.3 billion in K Certificates (K-113 Certificates), which are expected to settle on or about August 6, 2020.K-113 PricingDetailsCo-Lead Managers and Joint Bookrunners: Credit Suisse Securities (USA) LLC and BofA Securities, Inc.Co-Managers: Academy Securities Inc., Goldman, Sachs & Co. LLC, Morgan Stanley & Co. LLC and Performance Trust Capital Partners, LLCRating Agencies: Fitch Ratings, Inc. and DBRS, Inc.Related LinksThe K-113 Preliminary Offering Circular Supplement: http://www.freddiemac.com/mbs/data/k113oc.pdfFreddie...

Continue reading

CORRECTING AND REPLACING: THE COMMUNITY FINANCIAL CORPORATION Operating Results for the Three and Six Months Ended June 30, 2020

WALDORF, Md., July 31, 2020 (GLOBE NEWSWIRE) — On July 27, 2020, The Community Financial Corporation (NASDAQ: TCFC) (the “Company”), the holding company for Community Bank of the Chesapeake (the “Bank”), reported its results of operations for the second quarter and six months ended June 30, 2020 (the “Original Release”). Certain narrative disclosure in the Original Release require correction. The financial tables that accompany the release remain unchanged from the original release. Specifically, the second sentence of the third paragraph of the Original Release, and the second sentence of the second paragraph under the heading “Income Statement – Net Income”, have been corrected to report that the Company’s ROAA and ROACE were 0.65% and 6.64% for the six months ended June 30, 2020 compared to 0.88% and 9.41% in the six months...

Continue reading

Remuneration of Directors by distribution of Millicom shares

Remuneration of Directors by distribution of Millicom sharesLuxembourg, July 31, 2020 – Millicom International Cellular S.A. (“Millicom”) announces that, in accordance with the resolution of its shareholders at the annual general meeting on June 25, 2020, it has distributed a total of 32,358 shares to members of its Board of Directors as part of the non-executive director remuneration for the period from the date of the 2020 AGM to the 2021 AGM, to be held in May 2021.In accordance with the resolution the number of shares has been calculated based on the remuneration approved by the AGM and with reference to the closing share price of Millicom on the Nasdaq Stock Market in the US on July 2, 2020 ($26.27).Details of the distribution are disclosed on Millicom’s website.-END-For further information, please contactAbout MillicomMillicom (NASDAQ...

Continue reading

DAVIDsTEA Announces Results of Annual Meeting

MONTREAL, July 31, 2020 (GLOBE NEWSWIRE) — DAVIDsTEA Inc. (Nasdaq:DTEA) is pleased to announce that the five nominees listed in its management information circular dated June 25, 2020 were re-elected as directors at the Company’s annual meeting of shareholders held today in Montreal. According to proxies received and ballots cast, the votes were as follows:At the annual meeting, DAVIDsTEA’s shareholders also re-appointed Ernst & Young LLP, Chartered Professional Accountants, as DAVIDsTEA’s auditor.About DAVIDsTEADAVIDsTEA is a leading branded retailer and growing mass wholesaler of specialty tea, offering a differentiated selection of proprietary loose-leaf teas, pre-packaged teas, tea sachets and tea-related gifts and accessories on our e-commerce platform at www.davidstea.com and through 18 Company-owned and operated retail...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.